|
|
||||||||
1 Department of Anatomy and Neurobiology and 2 Department of Surgery, Dalhousie University, Halifax, Nova Scotia B3H 4H7; and 3 Department of Pharmacology, Faculty of Medicine, University of Montréal, Montréal, Québec, H4J 1C5 Canada
| |
ABSTRACT |
|---|
|
|
|---|
The intrinsic cardiac nervous system
is the final common integrator of regional cardiac function. The
ischemic myocardium modifies this nervous system. We sought to
determine the role that intrinsic cardiac neuronal P1
purinergic receptors play in transducing myocardial ischemia
and the subsequent reperfusion. The activity generated by ventricular
neurons was recorded concomitant with cardiac hemodynamic variables in
44 anesthetized pigs. Regional ventricular ischemia was induced
by briefly occluding (30 s) the ventral interventricular coronary
artery distal to the arterial blood supply of identified ventricular
neurons. Adenosine (100 µM) was administered to these neurons via
their local arterial blood supply during or immediately after transient
coronary artery occlusion. Occlusion was also performed following local
administration of adenosine A1
[8-cyclopentyl-1,3-dipropylxanthine (DPCPX)] or A2
[3,7-dimethyl-1-propargylxanthine (DMPX)] receptor blocking agents.
The activity generated by ventricular neurons was modified by transient
coronary artery occlusion and the subsequent reperfusion (|
|
112 ± 14 and 168 ± 34 impulses/min, respectively;
P < 0.01 vs. preischemic states). Locally
administered adenosine attenuated neuronal responses to reperfusion
(
75%; P < 0.01 compared with normal reperfusion)
but not ischemia. The neuronal stabilizing effects that
adenosine elicited during reperfusion persisted in the presence of DMPX
but not DPCPX. It is concluded that activation of neuronal adenosine
A1 receptors stabilizes the intrinsic cardiac nervous
system during reperfusion.
myocardium; ventricular neurons
| |
INTRODUCTION |
|---|
|
|
|---|
THE TERM REPERFUSION injury is used to describe a phenomenon that encompasses abnormal myocardial responses with reestablishment of oxygenated blood flow to the previous ischemic myocardium. The consequences of this response include myocardial cell injury, ranging from reversibly "stunned" myocardium to accelerated necrotic cell death (10). An additional clinical consequence is the generation of potentially lethal ventricular arrhythmias that can occur within seconds of the onset of reperfusion following coronary artery occlusion (10). The precise mechanisms involved in the generation of reperfusion-induced alterations in cardiac function remain elusive. One potential mechanism involves untoward activation of populations of intrinsic cardiac neurons. Excessive activation of specific populations of atrial neurons can induce negative cardiodynamic effects that include the genesis of cardiac arrhythmias (14). It is not known if ventricular myocardial ischemia/reperfusion can be transduced by the ventricular nervous system or whether the resultant neuronal responses (if any) can be modified pharmacologically. In the context of this investigation, the term transduction is employed to represent the capacity of the intrinsic cardiac nervous system to transduce cardiac sensory information, primarily by local circuit neurons, to efferent neurons regulating regional cardiac function.
Adenosine has received attention in the setting of reperfusion injury since it is known to exert cardioprotective and anti-arrhythmia effects (8). Adenosine is a by-product of catabolism within the ischemic myocardium, increasing severalfold in the ischemic myocardium (17). In addition to cardiomyocyte modulation, adenosine has also been demonstrated to elicit neuromodulatory effects on the cardiac autonomic nervous system. Adenosine-sensitive cardiac afferent neurons are located in nodose and dorsal root ganglia (7, 12, 19). Adenosine can also modify the activity generated by atrial neurons in vitro (3) or in vivo (13). The neuromodulator effects that adenosine exerts on ventricular neurons have yet to be determined. Furthermore, if purinergic intrinsic cardiac neurons are involved in the transduction of myocardial ischemia/reperfusion from cardiac afferent neurons, it is important to determine whether purinoceptor specificity exists in that process. If such specificity does exist, the intrinsic cardiac nervous system may be capable of modification in the presence of such pathology to stabilize cardiac function.
Therefore, the present study was devised to determine 1) whether ventricular ischemia/reperfusion can be transduced by the ventricular nervous system and, if that does occur, 2) whether purinergic receptors are involved in such transduction. Furthermore, we sought to determine if the responsiveness of the intrinsic cardiac nervous system to myocardial ischemic/ reperfusion injury could be modified by pharmacological means.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
General methods.
All experiments were performed in accordance with the guidelines for
animal experimentation described in "Guiding Principles for Research
Involving Animals and Human Beings" by the American Physiological
Society. Forty-four Hamshire-Duvoc pigs of either gender, weighing
20-30 kg, were studied. The animals were sedated with a
combination of ketamine (80 mg/kg iv) and Pentothal Sodium (20 mg/kg
iv). After the endotracheal intubation was performed, positive pressure
ventilation was initiated with 0.95 FIO2
and 0.05 FICO2 using a Bird Mark 7A
ventilator (Palm Springs, CA). Anesthesia was maintained with Pentothal
Sodium (10-15 mg/kg iv every 5 min) during surgical preparation.
Thereafter, during neuronal recording, anesthesia was maintained with
-chloralose (75 mg/kg iv bolus, with repeat doses of 12.5 mg/kg iv
as required). The adequacy of anesthesia was assessed at regular
intervals by applying noxious stimuli to a limb to determine reflex
withdrawal responses of a limb as well as to monitor jaw tone. The
animals, placed in a supine position, underwent a bilateral thoracotomy
through the fifth intercostal space. Once completed, the animals were then placed in a right lateral decubitus position and a ventrolateral pericardotomy was performed to expose the heart.
Operative procedures. A lead II ECG, left ventricular (LV) chamber pressure, and aortic pressure were monitored continuously throughout the experiments. LV chamber pressure was monitored via a Cordis (Miami, FL) #6 French pigtail catheter that was inserted into the outflow tract of the LV chamber via one femoral artery. Systemic arterial pressure was monitored via a Cordis #5 French catheter that was placed in the descending aorta via the other femoral artery. These catheters were attached to Bentley (Irvine, CA) Trantec model 800 transducers. Intrinsic neuronal activity, ECG, and LV pressure were recorded concomitantly on an Astromed MT9500 8 channel rectilinear chart recorder.
Recording neuronal activity.
A collection of porcine intrinsic cardiac neurons is located at the
bifurcation of the left main as well as ventral interventricular (VIV)
(analogous to the left anterior descending coronary artery in human)
and circumflex coronary arteries (Fig.
1). Neurons in this ganglionated plexus,
termed the VIV ganglionated plexus, are representative of those found
throughout the porcine intrinsic cardiac nervous system. This
ganglionated plexus was chosen for study because of the relative
density of its neurons and the fact that its arterial blood supply is
spared when the VIV coronary artery is occluded distal to its first
diagonal branch as the multiple smaller arteries that supply blood to
this collection of neurons originate cranial to that location.
|
at 1,000 Hz). To minimize
epicardial motion during each cardiac cycle, a circular ring of heavy
gauge wire was gently placed around the epicardial fat on the
cranioventral surface of the interventricular groove. Care was taken
not to comprise the underlying coronary artery blood flow with this
device. The tungsten microelectrode, mounted on a Marzhauser
micromanipulator (model 25033-10, Fine Scientific Tools, North
Vancouver, British Columbia), was used to explore the fat at varying
depths ranging from the surface of the fat to regions adjacent to
cardiac musculature. The reference electrode was attached to the
adjacent pericardium. A grounding electrode was attached to the heavy
gauge wire-stabilizing ring. Identified signals generated by
ventricular neurons were differentially amplified by a Princeton
Applied Research (Princeton, NJ) model 113 amplifier that had band-pass
filters set at 300 Hz to 10 kHz and an amplification range of 100 to
500×. The output of this device, further amplified (50-200×) and
filtered (bandwidth 100 Hz-2 kHz) by means of an optically isolated
amplifier (Applied Microelectronics Institute, Halifax, N. S.,
Canada), was led to a Nicolet (Madison, WI) model 207 oscilloscope and
to a Grass (Quincy, MA) AM8 Audio Monitor.
Loci in epicardial fat were identified in which action potentials with
signal-to-noise ratios greater than 3:1 could be recorded. Individual
units were identified by the amplitude and configuration of their
action potentials. With the use of these techniques and criteria, the
microelectrode does not record action potentials generated by axons of
passage but rather records action potentials generated by somata and/or
dendrites (4). Periodic motion at the recording site
occurred due to cardiac and respiratory dynamics, thereby inducing
minor fluctuations in the amplitude of individual action potentials
generated by a given unit over time. Fluctuations in the amplitude of
action potentials were found to vary by <10 µV over several minutes,
retaining their same configurations over time. Thus, action potentials
recorded in a given locus with the same configuration and amplitude
(±10 µV) were considered to be generated by a single unit.
Interventions. Ventricular mechanical sensory inputs to identified neurons were tested by gently touching epicardial loci on the ventral epicardial surface of the right and left ventricles with a saline-soaked cotton applicator. Mechanosensory inputs to identified neurons were further tested by transient occlusion (5 s) of the inferior vena cava. Chemosensory inputs to these neurons were then tested by applying the Na+ channel modifier veratridine (7.5 µM) and, subsequently, adenosine (100 µM) to ventricular epicardial sensory fields. These chemical agents were applied individually to the epicardium for 60-120 s via 2-cm × 2-cm gauze squares soaked with one chemical (~0.5 ml). After each chemical was removed, sensory fields were washed with normal saline (~2 ml/s) for 30 s, at least 5-10 min being allowed to elapse before the next intervention. The application of these chemicals to epicardial loci was repeated to ascertain whether spurious results could occur due to tachyphylaxis. Gauze squares soaked with room temperature normal saline were also applied to identified epicardial sensory fields to determine whether neuronal responses elicited by epicardial chemical application were due to vehicle effects or any mechanical effects elicited by the gauze squares.
Administration of chemicals to identified neurons via their local arterial blood supply. To administer various chemicals to the somata and dendrites of neurons identified in the ventral ventricular ganglionated plexus, a 24-French catheter was inserted in the VIV coronary artery at the level of its first diagonal branch (Fig. 1, thick black arrow). The cannula was threaded proximally (retrograde to flow) such that its tip was positioned just cranial of the origin of the small arteries that supplied blood to the ventral ventricular ganglionated plexus. The position of the catheter tip was confirmed by gentle palpation through the artery wall. The cannula was fixed in place with 2-3 ml of adhesive applied to the arterial wall. PE-15 tubing was inserted into this cannula, with a stopcock at its other end, to permit the administration of chemicals into the local arterial blood supply of identified neurons. Monitored hemodynamic indexes were unaffected by the placement of this cannula. Postmortem examination of appropriate catheter placement was confirmed by injecting methylene blue dye via this catheter into the regional coronary arteries.
The following pharmacological agents were infused via this catheter into the local arterial blood supply of identified neurons at rates of ~0.05 ml/s: adenosine (100 µM; 0.1 ml), the selective adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 1 mM, 1.0 ml), and the selective adenosine A2 receptor antagonist 3,7-dimethyl-1-propargylxanthine (DMPX; 1 mM, 1.0 ml). Chemicals, when locally administered, affected the somata of ventral ventricular neurons as well as tissues downstream such as ventricular sensory neurites and regional cardiomyocytes. In four preliminary test animals, different doses of each pharmacological agent were administered into the local coronary artery to determine whether when applied in increasing doses they entered the systemic circulation in sufficient quantities to alter monitored cardiovascular indexes. In all experiments, when a selective adenosine receptor antagonist was studied, the effectiveness of adenosine receptor blockade was confirmed subsequently by administering adenosine (100 µM; 0.5 ml) into the local arterial blood supply 5 and 60 min after administering DPCPX and DMPX.Myocardial ischemia. A 3-0 silk ligature, passed around the VIV coronary artery just distal to its first diagonal branch (Fig. 1, black arrow), was led through a snare to occlude that artery later in the experiments. Because investigated neurons derived their arterial blood supply from arteries proximal to this ligature, their arterial blood supply was not affected by these transient coronary artery occlusions. A 30-s coronary artery occlusion time was chosen to create each ischemic episode. This relatively short period of occlusion was chosen for two reasons. First, longer duration occlusions performed multiple times during the course of each experiment might have induced preconditioning. It has been demonstrated that myocardial preconditioning can be avoided if the periods of coronary artery occlusion are less than 1 min in duration (20). Second, in four preliminary experiments in which coronary artery occlusions of various durations (15 and 30 s as well as 1 and 2 min) were tested, it was found that multiple 30-s periods of occlusion elicited consistent neuronal responses. Occlusions longer than 30 s did not produce any further modification of neuronal activity, whereas occlusions less than 30-s duration produced inconsistent neuronal responses. Thus, 30-s occlusion times were employed for the remainder of the experiments. A minimum of 10 min was allowed to elapse between each coronary artery occlusion to allow neuronal and cardiovascular variables to return to baseline values. To ensure reproducibility of the ischemic/ reperfusion responses, multiple occlusions were performed during the course of each experiment. In a preliminary set of experiments involving eight animals, adenosine and then DPCPX plus DMPX were administered locally to investigated neurons during the ischemic episodes (at concentrations described above).
Myocardial reperfusion. In 15 separate pigs, following testing the epicardial sensory inputs depicted above, adenosine (100 µM, 0.1 ml) was administered into the arterial blood supply of the ventral ventricular ganglionated plexus. The local infusion of adenosine was begun at the time of onset of myocardial reperfusion (immediately on release of the vascular occluder); its administration lasted for the first 2-5 s after coronary arterial flow was reestablished.
Subsequently, the effects of preadministration of either DPCPX or DMPX (1 mM; 1 ml administered in random order into the local coronary artery blood) on neuronal activity responses elicited during reperfusion were studied in the absence or presence of adenosine. This was done to determine if local administration of adenosine A1 or A2 receptor antagonists affected the modulator effects that adenosine was capable of exerting on ventricular neurons during reperfusion.Data analysis.
Heart rate and LV chamber systolic pressure were measured for 30-s
periods of time before and during the peak responses elicited by each
intervention. Similarly, the activity generated by identified ventricular neurons was analyzed for 30-s periods of time before and
during each intervention. Data obtained before and during each
intervention are presented as means ± SE. Repeated-measures ANOVA
or paired t-tests with Bonferroni correction were used for statistical analysis of the effects elicited by each intervention, where appropriate. Each chemical tested elicited neuronal responses in
each animal. As has been found in the past (13), intrinsic cardiac neuronal activity either increased or decreased when exposed to
the interventions described above, including exogenous adenosine administration, depending on the population of neurons investigated. Thus, change in neuronal activity from baseline values was also assessed during each intervention [expressed as absolute value of the
delta change (|
|) in neuronal activity]. Significance values of
P < 0.05, 0.02, or 0.01 were used for these determinations.
| |
RESULTS |
|---|
|
|
|---|
Ventricular mechanosensory and chemosensory inputs.
When a gentle touch was applied to the epicardial surface of the right
or left ventricles of nine pigs, the activity generated by identified
neurons changed in each animal (Table 1).
Neuronal activity increased or decreased in response to gently touching a ventricular epicardial locus, depending on the population of neurons
studied. Epicardial application of veratridine also altered neuronal
activity, increasing or decreasing activity depending on the population
studied. On the other hand, when adenosine was applied to epicardial
loci at the dose studied, the activity generated by investigated
neurons was not modified. Transient occlusion of the inferior vena cava
induced minor reductions in LV chamber systolic pressure that were
accompanied by concomitant changes in intrinsic cardiac neuronal
activity. As has been found in the past (18), monitored
indexes were unaffected when equal volumes of saline were administered
into the blood supply of investigated neurons. Epicardial application
of saline did not alter monitored indexes.
|
Effects of ischemia on monitored indexes.
In 15 pigs, when the VIV coronary artery was occluded for 30 s,
the activity generated by the more centrally located ventricular neurons increased in 10 animals (Fig. 2);
the activity generated by neurons identified in the five remaining
animals decreased. Neuronal activity was changed from baseline values
(|
| change) by the brief periods of coronary artery occlusion
(Table 2). Activity changed even more
during the early reperfusion period (Figs. 2 and
3). Heart rate remained unchanged
throughout these brief periods of focal ventricular ischemia as
well as during reperfusion (control 154 ± 11 beats/min;
ischemia 156 ± 12 beats/min; reperfusion 155 ± 11 beats/min). During ischemia, LV chamber systolic pressure fell
slightly (113 ± 4 to 101 ± 4 mmHg; P < 0.01). This index returned to baseline values immediately with
reperfusion (114 ± 4 mmHg).
|
|
|
Adenosine and adenosine receptor antagonists. In the normally perfused hearts of 15 pigs when adenosine was administered into the local coronary artery blood supply of identified ventricular neurons, neuronal activity changed by a small amount (Table 2). No change in cardiovascular variables was identified during this intervention (heart rate 138 ± 14 to 141 ± 16 beats/min; LVP systolic 116.9 ± 4.3 to 116.7 ± 3.7 mmHg). Local vehicle administration did not alter monitored variables.
Locally administered DPCPX and DMPX (n = 15) exerted minor effects on the activity generated by investigated neurons (Table 2). No hemodynamic alterations were detected following local arterial administration of DPCPX and DMPX (LV pressure 113.5 ± 3.1 to 113.9 ± 2.6 mmHg; heart rate 135 ± 11 to 136 ± 11 beats/min, P = not significant). The dose of DPCPX and DMPX employed produced effective local adenosine receptor blockade during the rest of experiments as local administration of adenosine failed to elicit neuronal responses (|
| 8 ± 3 impulses/min
compared with baseline values; P = not significant) in
their presence.
Adenosine administered during ischemia.
In eight separate animals, neuronal activity responses to
ischemia were not affected by locally administered adenosine
(92 ± 52 vs. 127 ± 41 |
| impulses/min;
P = not significant). Neither were
ischemia-induced neuronal responses affected by the presence of
DPCPX and DMPX (51 ± 18 and 63 ± 24 |
| impulses/min,
respectively; P = not significant). Therefore, for the
rest of the experiments, we focused on neuronal responses elicited
during the reperfusion (immediate postischemia) phase.
Adenosine administered during reperfusion.
Local infusion of adenosine obtunded neuronal responses to reperfusion
(n = 15 pigs; Fig. 3). Adenosine reduced their
responsiveness to reperfusion by 75% (|
| impulses/min of
167.7 ± 34.2 to 41.9 ± 10.7 impulses; P < 0.01). Overall, adenosine returned intrinsic cardiac neuronal activity
toward baseline (preischemic) values whether excitatory or
depressor neuronal responses were induced initially during reperfusion
(Fig. 4). Thus, in the 13 animals in
which ventricular neuronal activity increased during reperfusion, local
administration of adenosine suppressed neuronal activity during repeat
reperfusion. In the two animals in which neuronal activity was
diminished during the reperfusion phase, adenosine administered during
reperfusion returned neuronal activity to baseline values (i.e.,
activity was greater than in the absence of adenosine).
|
Reperfusion and adenosine receptor blockade.
Adenosine was tested during reperfusion in the presence of the
A1 receptor antagonist DPCPX in seven other animals. After preadministered DPCPX, exogenously administered adenosine failed to
modify the neuronal effects of reperfusion (230.3 ± 63.8 vs. 216.6 ± 94.7 |
| impulses/min, comparing control responses
elicited during reperfusion to those induced in the presence of DPCPX, P = not significant; Fig. 4). Conversely,
preadministration of the A2 receptor antagonist DMPX to
seven different animals did not diminish the capacity of adenosine to
modify neuronal activity during reperfusion (230.9 ± 63 |
|
impulses/min before and 72.3 ± 41.3 |
| impulses/min after
DMPX; P < 0.02; Fig. 4).
| |
DISCUSSION |
|---|
|
|
|---|
As is found with canine atrial neurons (11), the porcine ventricular nervous system can transduce myocardial ischemia and the subsequent period of reperfusion injury (Fig. 2). This occurred despite the fact that the somata of investigated neurons were not directly involved in the ischemic process. The responsiveness (excitatory or inhibitory activity responses) of ventricular neurons to distal ventricular ischemia apparently was due to the summation of various inputs from an array of ventricular sensory neurites that were capable of transducing the mechanical and chemical milieu of the ventricle. Exogenously administered adenosine, acting principally via adenosine A1 receptors, modified ventricular neuronal responses to myocardial reperfusion but not to ischemia.
Adenosine, a by-product of catabolism within the ischemic cell, may arise from multiple cell types (15). Myocardial release of adenosine increases severalfold during myocardial ischemia (17). Adenosine has been shown to affect neurons in the central nervous system (2). It also affects neurons in autonomic ganglia associated with the gastrointestinal tract (6) and heart (3, 13) as well as sympathetic efferent postganglionic axons innervating coronary arteries (1). Adenosine affects cardiac sensory neurites associated with afferent neuronal somata in dorsal root (12) and nodose (19) ganglia. In contradistinction to these findings, adenosine did not modify ventricular sensory neurites that input to ventricular neurons identified in this study (Table 1). On the other hand, identified neurons did receive inputs from ventricular chemosensory neurites capable of transducing ion channel modifying agents such as veratridine (Table 1). These data imply that ventricular sensory inputs to investigated porcine ventricular neurons were capable of transducing chemicals other than adenosine, in addition to local deformation. The absence of neuronal responses elicited by epicardial application of adenosine, combined with an absence of hemodynamic perturbations when adenosine was administered directly to the somata and/or dendrites of ventral ventricular neurons (i.e., lack of efferent neuronal effects), suggests adenosine neuromodulation was principally via the local circuit neurons (interneurons).
Data generated from these experiments demonstrated a differential response of the intrinsic cardiac nervous system to myocardial ischemia, as opposed to the subsequent reperfusion injury phase. The capacity of ventricular neurons to transduce regional ventricular ischemia was not affected by adenosine administered exogenously to investigated somata and/or dendrites immediately before or during the ischemic episode. Conversely, intrinsic cardiac neuronal activity was modified when adenosine administration began immediately with initiation of reperfusion (Fig. 3). Presumably, the lack of effect of adenosine induced during the ischemic period was due, in part, to the fact that mechanosensory inputs to the intrinsic cardiac nervous system secondary to ischemia-induced local myocardial dyskinesia (9) would not have been influenced by locally applied adenosine. Furthermore, oxygen free radicals liberated by the ischemic myocardium (21) are capable of activating ventricular sensory neurites (18). Thus, the enhancement of multiple sensory inputs to the intrinsic cardiac nervous system in such a state presumably overwhelmed any demonstrable effects that adenosine receptor modification elicited on identified ventricular neurons.
During reperfusion, locally administered adenosine affected intrinsic cardiac neuronal activity (Fig. 3). Under these circumstances, adenosine acted to restore neuronal activity toward baseline (preischemic) values (c. f., Fig. 2). The stabilizing effects that adenosine imparted to the intrinsic cardiac nervous system during reperfusion were abrogated by the presence of an A1 receptor but not an A2 adenosine receptor antagonist (Fig. 4). These data indicate that activation of intrinsic cardiac neuron adenosine A1 receptors obtunds the responsiveness of ventricular neurons to reperfusion injury.
Adenosine has been shown to exert modulator effects on a number of cellular mechanisms associated with reperfusion injury. Specifically, adenosine A1 receptor activation produces alterations in local free radical generation (16) and K+ATP channel activity (5). Both of these cellular mechanisms are known to affect intrinsic cardiac neurons (18). In the experiments described herein, adenosine apparently influenced intrinsic cardiac local circuit neurons that were involved in translating myocardial reperfusion injury to cardiac efferent neurons, principally via their adenosine A1 receptors. As such, modulation of adenosine A1 receptors may be important in clinical situations such as during revascularization therapy (i.e., thrombolytic therapy or following coronary artery bypass grafting procedures) to suppress reperfusion-induced alterations in the intrinsic cardiac nervous system. Further studies are required to better elucidate the role of ventricular purinergic neurons involved in the reperfusion process to establish the possible clinical utility of adenosine receptor modulation in such circumstances.
Perspectives
Data derived from this study indicate that transient regional ventricular ischemia/reperfusion is transduced by the porcine ventricular nervous system. Stabilization of reperfusion-induced neuronal responses by adenosine A1 receptor activation indicates the importance of ventricular neuronal purinoceptors during ventricular reperfusion injury. These data suggest that therapy devised to modify adenosine A1-sensitive ventricular cardiac neurons may be of benefit in reducing cardiac reperfusion injury sequellae.| |
ACKNOWLEDGEMENTS |
|---|
The authors gratefully acknowledge the technical assistance of R. Livingston.
| |
FOOTNOTES |
|---|
The Medical Research Council of Canada (MT-10122) and the Nova Scotia Heart and Stroke Foundation supported this work.
Address for reprint requests and other correspondence: J. A. Armour, Centre de Recherche, Hôpital du Sacré-Coeur, 5400 boul. Gouin ouest, Montréal, Québec, B3H 4H7 Canada (E-mail: JA-Armour{at}crhsc.umontreal.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpregu.00333.2002
Received 6 June 2002; accepted in final form 14 November 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abe, T,
Morgan DA,
and
Gutterman DD.
Role of adenosine receptor subtypes in neural stunning of sympathetic coronary innervation.
Am J Physiol Heart Circ Physiol
272:
H25-H34,
1997
2.
Aden, U,
Leverin AL,
Hagberg H,
and
Fredholm BB.
Adenosine A(1) receptor agonism in the immature rat brain and heart.
Eur J Pharmacol
426:
185-192,
2001[ISI][Medline].
3.
Allen, TGJ,
and
Burnstock G.
The actions of adenosine 5'-triphosphate on guinea-pig intracardiac neurons in culture.
Br J Pharmacol
100:
269-276,
1990[ISI][Medline].
4.
Armour, JA,
and
Hopkins DA.
Activity of in situ canine left atrial ganglion neurons.
Am J Physiol Heart Circ Physiol
259:
H1207-H1215,
1990
5.
Baxter, GF,
and
Yellon DM.
ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation.
J Mol Cell Cardiol
31:
981-989,
1999[ISI][Medline].
6.
Cooke, HJ,
Wang Y,
Liu CY,
Zhang H,
and
Christofi FL.
Activation of neuronal adenosine A1 receptors suppresses secretory reflexes in the guinea pig colon.
Am J Physiol Gastrointest Liver Physiol
276:
G451-G462,
1999
7.
Dibner-Dunlap, ME,
Kinugawa T,
and
Thames MD.
Activation of cardiac sympathetic afferents: effects of exogenous adenosine and adenosine analogues.
Am J Physiol Heart Circ Physiol
265:
H395-H400,
1993
8.
Downey, JM,
Liu GS,
and
Thornton JD.
Adenosine and the anti-infarct effects of preconditioning.
Cardiovasc Res
27:
3-8,
1993
9.
Foreman, RD,
Blair RW,
Holmes HR,
and
Armour JA.
Correlation of activity generated by sympathetic afferent ventricular mechanosensory neurites with sensory field deformation in the normal and ischemic myocardium.
Am J Physiol Regul Integr Comp Physiol
276:
R976-R989,
1999.
10.
Hearse, DJ,
and
Bolli R.
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
Cardiovasc Res
26:
101-108,
1992
11.
Huang, MH,
Ardell JL,
Hanna BD,
Wolf SG,
and
Armour JA.
Effects of transient coronary artery occlusion on canine intrinsic cardiac neuronal activity.
Integr Physiol Behav Sci
28:
5-21,
1993[Medline].
12.
Huang, MH,
Horackova M,
Negoescu RM,
Wolf SG,
and
Armour JA.
Polysensory response characteristics of dorsal root ganglion neurones that may serve sensory functions during myocardial ischemia.
Cardiovasc Res
32:
503-515,
1996[ISI][Medline].
13.
Huang, MH,
Sylvén CA,
Pelleg A,
and
Armour JA.
Modulation of in situ canine intrinsic cardiac neurons by locally applied adenosine, ATP and analogs.
Am J Physiol Regul Integr Comp Physiol
265:
R914-R922,
1993
14.
Huang, MH,
Wolf SG,
and
Armour JA.
Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurons.
Cardiovasc Res
28:
636-642,
1994
15.
Kitakaze, M,
Hori M,
and
Kamada T.
Role of adenosine and its interaction with
-adrenoceptor activity in ischaemic and reperfusion injury of the myocardium.
Cardiovasc Res
27:
18-27,
1993[ISI][Medline].
16.
Manning, AS,
and
Hearse DJ.
Reperfusion-induced arrhythmias: mechanisms and prevention.
J Mol Cell Cardiol
16:
497-518,
1984[ISI][Medline].
17.
Rubio, R,
Berne RM,
and
Katori M.
Release of adenosine in reactive hyperemia of the dog heart.
Am J Physiol
216:
56-62,
1969
18.
Thompson, GW,
Horackova M,
and
Armour JA.
Sensitivity of canine intrinsic cardiac neurons to H2O2 and hydroxyl radical.
Am J Physiol Heart Circ Physiol
275:
H1431-H1440,
1998.
19.
Thompson, GW,
Horackova M,
and
Armour JA.
Chemotransduction properties of nodose ganglion cardiac afferent neurons in guinea-pigs.
Am J Physiol Regul Integr Comp Physiol
279:
R433-R439,
2000
20.
Vegh, A,
Komori S,
Szekeres L,
and
Parratt JR.
Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats.
Cardiovasc Res
26:
487-495,
1992[ISI][Medline].
21.
Wit, AL,
and
Janse MJ.
Reperfusion arrhythmias and sudden cardiac death: a century of progress towards an understanding of the mechanisms.
Circ Res
89:
741-743,
2001
This article has been cited by other articles:
![]() |
J. A. Armour Potential clinical relevance of the 'little brain' on the mammalian heart Exp Physiol, February 1, 2008; 93(2): 165 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Reichelt, L. Willems, J. G. Molina, C.-X. Sun, J. C. Noble, K. J. Ashton, J. Schnermann, M. R. Blackburn, and J. P. Headrick Genetic Deletion of the A1 Adenosine Receptor Limits Myocardial Ischemic Tolerance Circ. Res., February 18, 2005; 96(3): 363 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Armour Cardiac neuronal hierarchy in health and disease Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R262 - R271. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |